Is larotrectinib effective?

Larotrectinib (Larotrectinib) is a targeted therapy drug mainly used to treat tumors carrying NTRK gene fusion. NTRKGene fusion is a rare but specific tumor mutation that occurs in many tumor types. Larotrectinib generally shows significant efficacy in patients with tumors that have NTRK gene fusions. Clinical trial results showed that the drug was able to induce durable treatment responses in such patients, including significant responses in advanced, metastatic tumors. Due to its targeted nature, larotrectinib is often considered an innovative and effective treatment. However, the effect of the drug is still affected by individual differences, so the specific efficacy needs to be determined based on the patient's specific situation and the doctor's evaluation. Patients require close monitoring while taking larotrectinib to ensure treatment efficacy and safety.